Theratechnologies had a narrower commercial proposition, and when the European regulators pushed back, the economics of a second application apparently did not justify the spend
The drugmaker which was known as Mallinckrodt Pharmaceuticals before merging with Endo and rebranding as Keenova last year said that Xiaflex (collagenase clostridium histolyticum) met its objectives in a phase 3 trial in plantar fibromatosis patients and will be filed for approval in the new indication before the end of the year
many patients see 3% to 8% loss by the time they reach their target dose at week 6-8
However, they may take a tissue biopsy to confirm the findings and rule out more serious medical conditions
Samiec, Paula S, Carolyn Drews-Botsch, Elaine W Flagg, Joanne C Kurtz, Paul Sternberg, Robyn L Reed, et Dean P Jones
Metabolic and bariatric surgery as well as endoscopic procedures could be effective interventions for reducing weight and improving metabolic health
-1775582746855.png&w=3840&q=75)
